Tag Archive for: Start-Up for Transplant Treatments Has Set Its Sight on Billion-Dollar Market
Start-Up for Transplant Treatments Has Set Its Sight on Billion-Dollar Market
Synklino is developing an innovative drug to combat a virus that afflicts patients who receive organ and stem cell transplants. A recent investment from the BioInnovation Institute is moving the start-up from the discovery phase into development.